| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Cybin D/b/a Helus Pharma's insiders have accumulated 788,000 shares worth roughly $9.7M on balance. In the past 30 days, 2 insiders bought and 0 sold. Recent activity has leaned to the buy side.
Leading the buying is Halstead Michael (Chief Executive Officer), now holding an estimated $2.3M in HELP. Open-market purchases by a top executive tend to carry more weight than sales, which are often driven by diversification or scheduled 10b5-1 plans.
Classified under Biotechnology (Healthcare sector), HELP's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 4.75M | - | - | |
| Dir | 4.71M | - | - | |
| CEO | 168.6K | $2.27M | +100.0K | |
| CFO | 3.0K | $38.7K | +3.0K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Cavers Greg | Chief Financial Officer | Buy | 3,000 | $12.91 | $38,730.00 | New | |
| Sep 21, 2026 | Halstead Michael | Chief Executive Officer | Buy | 100,000 | $13.47 | $1,347,050.00 | +145.8% | |
| Sep 8, 2026 | Glavine Paul | Chief Growth Officer | Buy | 100,000 | $12.47 | $1,247,190.00 | +2.4% | |
| Sep 8, 2026 | So Eric H. L. | Executive Chair | Buy | 100,000 | $12.39 | $1,238,670.00 | +2.3% | |
| Sep 8, 2026 | Glavine Paul | Chief Growth Officer | Buy | 100,000 | $12.47 | $1,247,190.00 | +2.4% | |
| Sep 4, 2026 | So Eric H. L. | Executive Chair | Buy | 100,000 | $12.09 | $1,208,900.00 | +2.3% | |
| Sep 3, 2026 | Glavine Paul | Chief Growth Officer | Buy | 100,000 | $11.78 | $1,178,280.00 | +2.5% | |
| Sep 1, 2026 | So Eric H. L. | Executive Chair | Buy | 95,000 | $11.81 | $1,121,475.00 | +2.3% | |
| Aug 31, 2026 | Glavine Paul | Chief Growth Officer | Buy | 90,000 | $11.59 | $1,042,677.00 | +2.3% |